The role of the high-sensitivity C-reactive protein in patients with stable non-cystic fibrosis bronchiectasis

Pulmonary Medicine

Volumn , Issue , 2013, Pages

  Hsieh, Meng Heng ^a   Fang, Yueh Fu ^a   Chen, Guan Yuan ^a   Chung, Fu Tsai ^a   Liu, Yuan Chang ^a   Wu, Cheng Hsien ^a   Chang, Yu Chen ^a   Lin, Horng Chyuan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893850104     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2013/795140     Document Type: Article

References (42)

1. Barker A. F., Bronchiectasis. The New England Journal of Medicine 2002 346 18 1383 1393 2-s2.0-0037007684 10.1056/NEJMra012519 (Pubitemid 34754612)
2. Tsang K. W., Tipoe G. L., Bronchiectasis: not an orphan disease in the East. International Journal of Tuberculosis and Lung Disease 2004 8 6 691 702 2-s2.0-2942552402 (Pubitemid 38747145)
3. Fuschillo S., De Felice A., Balzano G., Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms. European Respiratory Journal 2008 31 2 396 406 2-s2.0-40649087414 10.1183/09031936. 00069007
4. Keistinen T., Säynäjäkangas O., Tuuponen T., Kivelä S.-L., Bronchiectasis: an orphan disease with a poorly-understood prognosis. European Respiratory Journal 1997 10 12 2784 2787 2-s2.0-2642705854 10.1183/09031936.97.10122784 (Pubitemid 28052788)
5. O'Donnell A. E., Bronchiectasis. Chest 2008 134 4 815 823 2-s2.0-54249161970 10.1378/chest.08-0776
6. Roberts H. J., Hubbard R., Trends in bronchiectasis mortality in England and Wales. Respiratory Medicine 2010 104 7 981 985 2-s2.0-77952854603 10.1016/j.rmed.2010.02.022
7. O'Donnell A. E., Barker A. F., Ilowite J. S., Fick R. B., Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. Chest 1998 113 5 1329 1334 2-s2.0-0031901989 (Pubitemid 28223825)
8. Pasteur M. C., Bilton D., Hill A. T., British thoracic society guideline for non-CF bronchiectasis. Thorax 2010 65 supplement 1 i1 i58 2-s2.0-77955283910 10.1136/thx.2010.136119
9. Ooi G. C., Khong P. L., Chan-Yeung M., Ho J. C. M., Chan P. K. S., Lee J. C. K., Lam W. K., Tsang K. W. T., High-resolution CT quantification of bronchiectasis: clinical and functional correlation. Radiology 2002 225 3 663 672 2-s2.0-0036892738 (Pubitemid 35387100)
10. Roberts H. R., Wells A. U., Rubens M. B., Cole P. J., Hansell D. M., Milne D. G., Kolbe J., Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax 2000 55 3 198 204 2-s2.0-0034066416 10.1136/thorax.55.3.198 (Pubitemid 30245969)
11. Sheehan R. E., Wells A. U., Copley S. J., Desai S. R., Howling S. J., Cole P. J., Wilson R., Hansell D. M., A comparison of serial computed tomography and functional change in bronchiectasis. European Respiratory Journal 2002 20 3 581 587 2-s2.0-0036736561 10.1183/09031936.02.00284602
12. Reiff D. B., Wells A. U., Carr D. H., Cole P. J., Hansell D. M., CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. American Journal of Roentgenology 1995 165 2 261 267 2-s2.0-0029093268
13. Grenier P., Cordeau M.-P., Beigelman C., High-resolution computed tomography of the airways. Journal of Thoracic Imaging 1993 8 3 213 229 2-s2.0-0027207212 (Pubitemid 23197380)
14. McGuinness G., Naidich D. P., Bronchiectasis: CT/clinical correlations. Seminars in Ultrasound CT and MRI 1995 16 5 395 419 2-s2.0-0028834242
15. Schaaf B., Wieghorst A., Aries S.-P., Dalhoff K., Braun J., Neutrophil inflammation and activation in bronchiectasis: comparison with pneumonia and idiopathic pulmonary fibrosis. Respiration 2000 67 1 52 59 2-s2.0-0034000732 (Pubitemid 30114166)
16. Mak J. C. W., Ho S. P., Leung R. Y. H., Ho P. L., Ooi C., Tipoe G. L., Yan C., Ip M. S. M., Lam W. K., Tsang K. W. T., Elevated levels of transforming growth factor- β 1 in serum of patients with stable bronchiectasis. Respiratory Medicine 2005 99 10 1223 1228 2-s2.0-24344442810 10.1016/j.rmed.2005.02.039 (Pubitemid 41245307)
17. Wilson C. B., Jones P. W., O'Leary C. J., Hansell D. M., Dowling R. B., Cole P. J., Wilson R., Systemic markers of inflammation in stable bronchiectasis. European Respiratory Journal 1998 12 4 820 824 2-s2.0-0031722626 10.1183/09031936.98.12040820 (Pubitemid 28491651)
18. Pepys M. B., Hirschfield G. M., C-reactive protein: a critical update. Journal of Clinical Investigation 2003 111 12 1805 1812 2-s2.0-0042744797 10.1172/JCI200318921 (Pubitemid 38057722)
19. Ridker P. M., High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001 103 13 1813 1818 2-s2.0-0035799331 (Pubitemid 32291421)
20. Kaplan M. J., Management of cardiovascular disease risk in chronic inflammatory disorders. Nature Reviews 2009 5 4 208 217 2-s2.0-67650504852 10.1038/nrrheum.2009.29
21. Everett B. M., Kurth T., Buring J. E., Ridker P. M., The Relative Strength of C-Reactive Protein and Lipid Levels as Determinants of Ischemic Stroke Compared With Coronary Heart Disease in Women. Journal of the American College of Cardiology 2006 48 11 2235 2242 2-s2.0-33845217662 10.1016/j.jacc.2006.09.030 (Pubitemid 44855447)
22. Ridker P. M., Stampfer M. J., Rifai N., Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. Journal of the American Medical Association 2001 285 19 2481 2485 2-s2.0-0035897688 (Pubitemid 32433842)
23. Cesari M., Penninx B. W. J. H., Newman A. B., Kritchevsky S. B., Nicklas B. J., Sutton-Tyrrell K., Rubin S. M., Ding J., Simonsick E. M., Harris T. B., Pahor M., Inflammatory markers and onset of cardiovascular events: results from the health ABC study. Circulation 2003 108 19 2317 2322 2-s2.0-0242610488 10.1161/01.CIR.0000097109.90783.FC (Pubitemid 37413536)
24. Yeh E. T. H., Willerson J. T., Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation 2003 107 3 370 372 2-s2.0-0037469179 10.1161/01.CIR.0000053731.05365.5A (Pubitemid 36158035)
25. Brody A. S., Klein J. S., Molina P. L., Quan J., Bean J. A., Wilmott R. W., High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. Journal of Pediatrics 2004 145 1 32 38 2-s2.0-3242693509 10.1016/j.jpeds.2004. 02.038 (Pubitemid 38962449)
26. ATS statement: guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine 2002 166 1 111 117
27. Loebinger M. R., Wells A. U., Hansell D. M., Chinyanganya N., Devaraj A., Meister M., Wilson R., Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. European Respiratory Journal 2009 34 4 843 849 2-s2.0-70349637821 10.1183/09031936.00003709
28. Onen Z. P., Eris Gulbay B., Sen E., Akkoca Yildiz Ö., Saryal S., Acican T., Karabiyikoglu G., Analysis of the factors related to mortality in patients with bronchiectasis. Respiratory Medicine 2007 101 7 1390 1397 2-s2.0-34249666760 10.1016/j.rmed.2007.02.002 (Pubitemid 46832240)
29. Weinhold B., Rüther U., Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. Biochemical Journal 1997 327 2 425 429 2-s2.0-0030668555 (Pubitemid 27477818)
30. Yoshida N., Ikemoto S., Narita K., Sugimura K., Wada S., Yasumoto R., Kishimoto T., Nakatani T., Interleukin-6, tumour necrosis factor α and interleukin-1 β in patients with renal cell carcinoma. British Journal of Cancer 2002 86 9 1396 1400 2-s2.0-0037029701 10.1038/sj.bjc.6600257 (Pubitemid 34548059)
31. Spector T. D., Hart D. J., Nandra D., Doyle D. V., Mackillop N., Gallimore J. R., Pepys M. B., Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis and Rheumatism 1997 40 4 723 727 2-s2.0-0030966943 10.1002/art.1780400419 (Pubitemid 27157579)
32. Pradhan A. D., Manson J. E., Rifai N., Buring J. E., Ridker P. M., C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association 2001 286 3 327 334 2-s2.0-0035908632 (Pubitemid 32656163)
33. De Torres J. P., Pinto-Plata V., Casanova C., Mullerova H., Córdoba-Lanús E., Muros De Fuentes M., Aguirre-Jaime A., Celli B. R., C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest 2008 133 6 1336 1343 2-s2.0-45949086220 10.1378/chest.07-2433 (Pubitemid 351892988)
34. Takemura M., Matsumoto H., Niimi A., Ueda T., Matsuoka H., Yamaguchi M., Jinnai M., Muro S., Hirai T., Ito Y., Nakamura T., Mio T., Chin K., Mishima M., High sensitivity C-reactive protein in asthma. European Respiratory Journal 2006 27 5 908 912 2-s2.0-33845497667 10.1183/09031936.06.00114405 (Pubitemid 44911102)
35. Gaga M., Bentley A. M., Humbert M., Barkans J., O'Brien F., Wathen C. G., Kay A. B., Durham S. R., Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax 1998 53 8 685 691 2-s2.0-0031847529 (Pubitemid 28378485)
36. Lee A. L., Button B. M., Ellis S., Stirling R., Wilson J. W., Holland A. E., Denehy L., Clinical determinants of the 6-Minute Walk Test in bronchiectasis. Respiratory Medicine 2009 103 5 780 785 2-s2.0-63149191179 10.1016/j.rmed.2008.11.005
37. Edwards E. A., Narang I., Li I., Hansell D. M., Rosenthal M., Bush A., HRCT lung abnormalities are not a surrogate for exercise limitation in bronchiectasis. European Respiratory Journal 2004 24 4 538 544 2-s2.0-6444242414 10.1183/09031936.04.00142903 (Pubitemid 39406125)
38. Dupont M., Gacouin A., Lena H., Lavoué S., Brinchault G., Delaval P., Thomas R., Survival of patients with bronchiectasis after the first ICU stay for respiratory failure. Chest 2004 125 5 1815 1820 2-s2.0-2442557854 10.1378/chest.125.5.1815 (Pubitemid 38648416)
39. Kroegel C., Schüler M., Förster M., Braun R., Grahmann P. R., Evidence for eosinophil activation in bronchiectasis unrelated to cystic fibrosis and bronchopulmonary aspergillosis: discrepancy between blood eosinophil counts and serum eosinophil cationic protein levels. Thorax 1998 53 6 498 500 2-s2.0-0031781556 (Pubitemid 28308067)
40. Santamaria F., Montella S., Pifferi M., Ragazzo V., De Stefano S., De Paulis N., Maglione M., Boner A. L., A descriptive study of non-cystic fibrosis bronchiectasis in a pediatric population from central and southern Italy. Respiration 2009 77 2 160 165 2-s2.0-61649111141 10.1159/000137510
41. Cole P., Wilson R., Host-microbial interrelationships in respiratory infection. Chest 1989 95 3 2-s2.0-0024603204
42. Tsang K. W., Tan K. C., Ho P. L., Ooi G. C., Ho J. C., Mak J., Tipoe G. L., Ko C., Yan C., Lam W. K., Chan-Yeung M., Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax 2005 60 3 239 243 2-s2.0-20144377363 10.1136/thx.2002.003236 (Pubitemid 40380285)